Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma
Clinical trial NCT02297529 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02297529
- Sponsor
- Amgen
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.